Recombinant Human bFGF/FGF-2

Recombinant Human bFGF/FGF-2

Size1:10μg price1:$40
Size2:50μg price2:$90
SKU: PEH2501 Category: Cytokines Tags: ,

Datasheet

Name

Recombinant Human BMP-7

Purity

Greater than 98% as determined by reducing SDS-PAGE

Endotoxin level

≤10 EU/mg

Construction

Recombinant Human BMP-7 is produced by our Mammalian cell expression system and the target gene encoding Met316-His431 is expressed.

Accession #

P18075

Host

Human Cells

Species

Human

Predicted Molecular Mass

13.1 kDa

Buffer

Lyophilized From PBS,pH 7.4

Form

Shipping

The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Reconstitution

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

 

 

 

Alternative Names

Bone morphogenetic protein 7; BMP-7; Osteogenic protein 1 (OP-1); Eptotermin alfa; BMP7; OP1

 

Background

Bone morphogenetic protein 7 (BMP7), also known as osteogenic protein-1 (OP-1) is a member of Transforming growth factor-β (TGF-β) family of proteins. Bone morphogenetic proteins were discovered in 1965 by Marshal Urist, of which BMP7 is of particular interest in this review being a leptin-independent anorexinogen and having role in energy expenditure in the brown adipose tissue, which makes it a potential target for preventing/treating obesity. As it has been established that Obesity displays a state of leptin-resistance, thus a protein-like BMP7 which acts through a leptin-independent pathway could give new therapeutic directions.

 

Note

For Research Use Only , Not for Diagnostic Use.